Truist initiated coverage of Synovus (SNV) with a Buy rating and $56 price target The bank, which the firm sees as in the “middle innings” of a self-help journey, is focused on investing in organic growth and delivering top-tier profitability with improved credit quality, the analyst tells investors.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNV:
- Synovus price target lowered to $48 from $52 at Evercore ISI
- Synovus price target lowered to $60 from $65 at DA Davidson
- Synovus price target lowered to $52 from $64 at RBC Capital
- Synovus price target lowered to $46 from $52 at Stephens
- Synovus price target lowered to $52 from $58 at Keefe Bruyette